This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
226 posters, 5 topics, 20 sessions, 598 authors, 292 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
14-15 May 2026 | Liverpool Convention Centre

7162747
Quality Improvement
Why not Remifentanil PCA? From “Can we?” to “We do” in labour analgesia
Muhammed Elgharabawy, Sher Khurram, Priya Sharma, Nitish Updhyay, Mahmoud Elhefnawy
Department of Anaesthesia, Liverpool Women’s Hospital
INTRODUCTION
Labour pain is highly variable, and no single analgesic technique meets all women’s needs. While epidural analgesia remains the gold standard, a substantial proportion of women either decline it or are unable to receive it. At Liverpool Women’s Hospital (LWH), epidural uptake is approximately 25%, meaning that around 75% of women rely on alternative forms of labour analgesia.
Remifentanil patient-controlled analgesia (rPCA) is a recognised alternative, with evidence demonstrating comparable maternal satisfaction and obstetric outcomes. However, its wider adoption has been limited by concerns regarding safety, monitoring requirements, and staff workload.
Historically, at LWH, rPCA utilisation was low, reserved for exceptional circumstances, and often associated with negative staff perceptions.
Aim
To implement remifentanil PCA as a standard analgesia option for all women in labour and evaluate uptake, efficacy, staff/patient experience.
Methods
A multidisciplinary quality improvement project including:
Protocol & Patient Information
Staff Engagement & Education
Evaluation
Conclusion
References: